Could the anticipated first 2-drug single-tablet regimen for initial HIV treatment change the landscape for initial ART regimens?
Could pharmacy-based PrEP change the future of HIV prevention?
To eliminate a virus that affects 2.4 million patients in the United States, we must launch a multifaceted attack. Pharmacists can play a critical role in increasing HCV screening efforts nationwide.
Learn how nurse practitioners, physician assistants, and pharmacists are joining the fight to increase PrEP uptake among individuals at high risk for HIV infection.
How can community pharmacists improve HIV care? Here’s my take.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.